Collaborative Studies on Alzheimer and Related Diseases

The summary for the Collaborative Studies on Alzheimer and Related Diseases grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Collaborative Studies on Alzheimer and Related Diseases: The NIA and NINDS encourage wider use of data and samples generated by grants supported by the institute(s) including the Alzheimers Disease Centers (ADCs). The purpose of this RFA is to accelerate collaborative cross-disciplinary and multi-institutional approaches that will contribute new and vital information about the clinical and pathological course of normal aging and the neurodegenerative diseases associated with aging. This RFA requires the utilization of data and/or samples from at least three currently funded NIA ADCs with the possibility of using additional relevant data or samples from outside of the Centers. The project must use the National Alzheimers Coordinating Center (NACC) http://www.alz.washington.edu/ for expert advice on planning, study design, and also utilize NACC for statistical analyses and data management during conduct of the research projects. Applicants can be from the Alzheimers Disease Centers, the Morris K. Udall Centers, or the research community at large. There should be a plan to share data originating from these studies by archiving them at NACC or another appropriate National databank so that other investigators will be able to conduct additional analyses when appropriate. There must also be a plan to encourage sample utilization after the current study. This is a research opportunity for scientists both within and outside the ADCs to gain access to unique resources related to Alzheimers Disease, other neurodegenerative diseases, and normal aging and to support collection of new data and samples. Applicants can also propose to utilize Center data and samples to investigate other age-related neurodegenerative diseases, such as Vascular dementia, Parkinsons dementia, Lewy Body disease, Fronto-Temporal dementia, as well as study psychiatric symptoms associated with dementia, sociobehavioral aspects of dementia, and management and care of dementia patients. The National Institute of Neurological Disorders and Stroke (NINDS) is interested in those specific applications which include the Morris K. Udall Centers of Excellence, or other Parkinsons research centers, in the pursuit of those research objectives focused on Parkinson's Disease (PD) or related parkinsonisms. The PD center need not be located with ADCs, but collaboration with those ADCs with existing samples and data sets focused on PD is required. Specific scientific projects of interest include the use of clinico-pathological correlations to study mechanisms of pathogenesis in PD or other parkinsonian conditions, characterization of the pathological features of these conditions, and the collection of patient data on their associated symptoms.